Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
AngioDynamics (ANGO)
NASDAQ:ANGO
Holding ANGO?
Track your performance easily
ANGO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$5.26 - $13.13
Previous CloseN/A
Volume2.49M
Average Volume (3M)678.30K
Market Cap
$525.81M
Enterprise Value$234.41M
Total Cash (Recent Filing)$48.76M
Total Debt (Recent Filing)$91.32M
Price to Earnings (P/E)―
Beta0.31
Next Earnings
Apr 03, 2025EPS Estimate
-0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.04
Shares Outstanding40,634,250
10 Day Avg. Volume812,868
30 Day Avg. Volume678,305
Standard Deviation0.14
R-Squared0.05
Alpha-0.00603
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.30
Price to Cash Flow (P/CF)-5.20
P/FCF Ratio0.00
Enterprise Value/Market Cap0.45
Enterprise Value/Revenue0.82
Enterprise Value/Gross Profit1.52
Enterprise Value/Ebitda-2.28
Forecast
1Y Price Target
$14.50Price Target Upside12.06% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
AngioDynamics News
PremiumCompany Announcements
AngioDynamics, Inc. Reports Growth in Med Tech SegmentBulls Say, Bears Say
Bulls Say
Clinical Data And Market ExpansionThe company's pivotal PRESERVE clinical study showed 84% of men were free from in-field, clinically significant disease at 12 months post-procedure, highlighting the effectiveness of the NanoKnife system.
Market Growth And Financial GuidanceManagement reiterated entire FY25 guidance, with revenue expected in the range of $282M-$288M, highlighting strong growth expectations driven by the Med Tech segment.
Regulatory ApprovalFDA approves NanoKnife System for prostate tissue ablation, providing a minimally invasive option for prostate treatment compared to conventional surgery or radiotherapy.
Bears Say
Cash FlowThe stock reaction is driven by the seasonally high cash burn.
Future ProspectsNanoKnife has the most catalysts ahead, but the impact of those may not come until late FY25 or early FY26.
RevenueThe stock reaction is driven by missing the consensus revenue estimate.
---
Ownership Overview
4.15% Insiders
17.49% Mutual Funds
26.04% Other Institutional Investors
40.32% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ANGO FAQ
What was AngioDynamics’s price range in the past 12 months?
AngioDynamics lowest stock price was $5.26 and its highest was $13.13 in the past 12 months.
What is AngioDynamics’s market cap?
AngioDynamics’s market cap is $525.81M.
When is AngioDynamics’s upcoming earnings report date?
AngioDynamics’s upcoming earnings report date is Apr 03, 2025 which is in 84 days.
How were AngioDynamics’s earnings last quarter?
AngioDynamics released its earnings results on Jan 08, 2025. The company reported -$0.04 earnings per share for the quarter, beating the consensus estimate of -$0.11 by $0.07.
Is AngioDynamics overvalued?
According to Wall Street analysts AngioDynamics’s price is currently Undervalued.
Does AngioDynamics pay dividends?
AngioDynamics does not currently pay dividends.
What is AngioDynamics’s EPS estimate?
AngioDynamics’s EPS estimate is -0.12.
How many shares outstanding does AngioDynamics have?
AngioDynamics has 40,634,250 shares outstanding.
What happened to AngioDynamics’s price movement after its last earnings report?
AngioDynamics reported an EPS of -$0.04 in its last earnings report, beating expectations of -$0.11. Following the earnings report the stock price went up 37.66%.
Which hedge fund is a major shareholder of AngioDynamics?
Among the largest hedge funds holding AngioDynamics’s share is Royce & Associates LLC. It holds AngioDynamics’s shares valued at 8M.
---
AngioDynamics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$14.50 (12.06% Upside)
$14.50 (12.06% Upside)
Blogger Sentiment
Bullish
ANGO Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 374.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $5.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 5.1%
Last 30 Days ▲ 1.7%
Last 30 Days ▲ 1.7%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
102.82%
12-Months-Change
Fundamentals
Return on Equity
-120.32%
Trailing 12-Months
Asset Growth
-41.65%
Trailing 12-Months
Company Description
AngioDynamics
AngioDynamics, Inc. (ANGO) is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease, and oncology. The company operates in the healthcare sector, focusing on the development and commercialization of a wide range of medical devices that improve patient outcomes and enhance procedural efficiencies. AngioDynamics is committed to advancing the quality of patient care through its comprehensive product portfolio, which includes vascular therapies, radiofrequency ablation systems, and other advanced medical technologies.
---
ANGO Company Deck
---
ANGO Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a strong performance in revenue growth and profitability, especially within the Med Tech segment, driven by innovations like AlphaVac and NanoKnife. However, challenges persist in Med Device revenue stagnation and manufacturing transition costs, tempering overall financial improvements.Read More>---
ANGO Stock 12 Month Forecast
Average Price Target
$14.50
▲(12.06% Upside)
Technical Analysis
Best Analysts Covering ANGO
1 Year
1 Year Success Rate
10/11 ratings generated profit
1 Year Average Return
+25.37%
reiterated a buy rating last month
Copying Yi Chen's trades and holding each position for 1 Year would result in 90.91% of your transactions generating a profit, with an average return of +25.37% per trade.
---